Acura Pharma names interim CEO
Jones has been working with Acura Pharma since April 2008 as the senior vice president and chief operating officer. Jones succeeds Andy Reddick, who passed away on 28
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.